Abstract Since 2005, the Advisory Committee on Immunization Practices (ACIP) has
recommended a tetanus toxoid, reduced diphtheria toxoid, and acellular pertussis (Tdap) …

Background: The high coverage for≥ 3 pertussis vaccine doses among Taiwanese children
might not imply timely vaccination. Recently, resurgence of pertussis and challenges with …

An observational post-licensure (Phase IV) retrospective large-database safety study was
conducted at Kaiser Permanente, a US integrated medical care organization, to assess the …

Purpose: To examine recent evidence concerning the health benefits and cost effectiveness
of replacing a single dose of adult tetanus/diphtheria vaccine with a single dose of …

Reduced-antigen-content diphtheria-tetanus-acellular pertussis (dTpa) vaccine, Boostrix™,
is indicated for booster vaccination of children, adolescents and adults. The original prefilled …

We assessed the immunogenicity and safety of the combined diphtheria-tetanus-acellular
pertussis-inactivated poliovirus/Haemophilus influenzae type b vaccine (DTPa-IPV/Hib) in …

Availability of combined tetanus-diphtheria-acellular pertussis (Tdap) vaccines for adults
offers a new pertussis prevention strategy for the US. Successful uptake of Tdap vaccine will …

Tetanus, diphtheria, and acellular pertussis vaccine (Tdap) is recommended for all adults in
Canada but uptake is low. This study measured the knowledge, attitudes, beliefs, and …

OBJECTIVE: To evaluate antibody persistence one year after three-dose primary
vaccination and booster immune response during the second year of life for a fully liquid …

Background: Adult formulation tetanus and diphtheria toxoids and acellular pertussis
vaccines (Tdap) have been developed to prevent pertussis in adolescents and adults. There …